{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:08:36Z","timestamp":1790402916002,"version":"4.1.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>We evaluated long-term outcomes of 288 children with refractory-Langerhans cell histiocytosis (R-LCH) from 26 countries, who were prescribed off-label MAPK inhibitors (MAPKis) according to clinical indications. MAPKi indications included 148 R-risk-organ\u2013positive (R-RO+), 67 R-risk-organ\u2013negative (R-RO\u2013), 13 lung destruction (lung), 9 sclerosing cholangitis (SC), 49 neurodegeneration (ND), and 2 diabetes insipidus (DI) cases. Median ages at diagnosis and MAPKi onset were 1.3 and 2.3 years, respectively, with median follow-up of 3.7 years (1166 person-years). Agents mostly prescribed as monotherapies were 184 prescriptions of vemurafenib, 115 of dabrafenib, 3 of encorafenib, 42 of cobimetinib, 45 of trametinib, and\/or 1 prescription of binimetinib; followed 51 times by various chemotherapies or hematopoietic stem-cell transplantation, or 28 times by combined anti-BRAF\u2013anti-MEK. Short-term responses (&amp;lt;8 weeks) ranged from 98% (R-RO+ and R-RO\u2013), to 30% (lung) to none (ND, DI, and SC); although long-term lung and ND responses could be observed. Skin rash was the most frequent adverse event (\u223c55%), and 7 others included 1 case of cardiomyopathy and 6 of retinitis. Five developed MAPKi-unrelated tumors and 9 patients died. Five-year survival was 98%. After 113 patients with R-LCH discontinued MAPKi, 69 experienced disease reactivation. None of the various empirical maintenance therapies were able to prevent secondary reactivation. Among the 143 assessable patients without ND-LCH at MAPKi onset, 60 developed ND (45%, 5-year risk). MAPKis appeared to be safe and effective in children with R-RO+\/RO\u2013LCH, whereas other indications\u2019 responses were less frequent or occurred later. Further studies are needed to find effective maintenance-therapy approaches, particularly to prevent frequently observed secondary ND.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018651","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T22:54:10Z","timestamp":1770936850000},"page":"3733-3743","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-146X","authenticated-orcid":false,"given":"Jean","family":"Donadieu","sequence":"first","affiliation":[{"name":"1French Reference Center for Langerhans Cell Histiocytosis, Assistance Publique des Hopitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-0624","authenticated-orcid":false,"given":"Dmitry","family":"Evseev","sequence":"additional","affiliation":[{"name":"2Department of Hematopoietic Stem Cell Transplantation, Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia"},{"name":"3Division of Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, Kepler University Hospital, Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-5744","authenticated-orcid":false,"given":"Francesco","family":"Pegoraro","sequence":"additional","affiliation":[{"name":"4Department of Hematology and Oncology, Meyer Children\u2019s Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-9812","authenticated-orcid":false,"given":"Elena","family":"Sieni","sequence":"additional","affiliation":[{"name":"4Department of Hematology and Oncology, Meyer Children\u2019s Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Slater","sequence":"additional","affiliation":[{"name":"5Department of Pediatric Hemato-Oncology, Great Ormond Street Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2059-4814","authenticated-orcid":false,"given":"Caroline","family":"Hutter","sequence":"additional","affiliation":[{"name":"6St Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-0137","authenticated-orcid":false,"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[{"name":"7Hospital Universitario de Cruces, Instituto de Investigaci\u00f3n Sanitaria Biocruces Bizkaia, Universidad Pa\u00eds Vasco Euskal Herriko Unibertsitatea, Unidad de Hematolog\u00eda y Oncolog\u00eda Pedi\u00e1trica, Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-3439","authenticated-orcid":false,"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[{"name":"8Klinik f\u00fcr Kinder- und Jugendmedizin Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cor","family":"van den Bos","sequence":"additional","affiliation":[{"name":"9Department of Hemato-Oncology, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Simonin","sequence":"additional","affiliation":[{"name":"1French Reference Center for Langerhans Cell Histiocytosis, Assistance Publique des Hopitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ahlmann","sequence":"additional","affiliation":[{"name":"10Department of Pediatric Hematology and Oncology, University Children\u2019s Hospital, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Barkaoui","sequence":"additional","affiliation":[{"name":"1French Reference Center for Langerhans Cell Histiocytosis, Assistance Publique des Hopitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-7129","authenticated-orcid":false,"given":"Solenne","family":"Le Louet","sequence":"additional","affiliation":[{"name":"1French Reference Center for Langerhans Cell Histiocytosis, Assistance Publique des Hopitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Chevallier","sequence":"additional","affiliation":[{"name":"1French Reference Center for Langerhans Cell Histiocytosis, Assistance Publique des Hopitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-3111","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Chalard","sequence":"additional","affiliation":[{"name":"11Department of Radiology, Assistance Publique\u2013H\u00f4pitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"5Department of Pediatric Hemato-Oncology, Great Ormond Street Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Holzhauer","sequence":"additional","affiliation":[{"name":"12Pediatric Hematology, Oncology and Stem Cell Transplantation, Charit\u00e9\u2013University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Beutel","sequence":"additional","affiliation":[{"name":"13P\u00e4diatrische H\u00e4matologie und Onkologie Zentrum f\u00fcr Kinder- und Jugendmedizin, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Haenicke","sequence":"additional","affiliation":[{"name":"14Pediatric Oncology, Helios Health Institute, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[{"name":"15Klinik f\u00fcr P\u00e4diatrische H\u00e4matologie und Onkologie, Universtit\u00e4tsklinikum Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Garcia-Obregon","sequence":"additional","affiliation":[{"name":"16Pediatric Oncology Group, Physiology Department, Biobizkaia Health Research Institute, Universidad del Pa\u00eds Vasco Euskal Herriko Unibertsitatea, Leioa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8507-1670","authenticated-orcid":false,"given":"Lorena","family":"Valero-Arrese","sequence":"additional","affiliation":[{"name":"17Paediatric Oncology and Haematology Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ruano","sequence":"additional","affiliation":[{"name":"18Department of Pediatric Hematology and Oncology, Hospital Infantil, Universitario Ni\u00f1o Jes\u00fas, Autonomous University of Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara Andr\u00e9s","family":"Moreno","sequence":"additional","affiliation":[{"name":"19Unidad de Oncolog\u00eda Pedi\u00e1trica, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Habes","sequence":"additional","affiliation":[{"name":"20Service d\u2019H\u00e9patologie P\u00e9diatrique, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Universitaire Kremlin\u2013Bic\u00e9tre, Kremlin\u2013Bic\u00e9tre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lacaille","sequence":"additional","affiliation":[{"name":"21Service d\u2019H\u00e9patologie P\u00e9diatrique, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Universitaire Necker\u2013Enfants Maladies, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-687X","authenticated-orcid":false,"given":"Val\u00e9rie","family":"McLin","sequence":"additional","affiliation":[{"name":"22Centre Suisse du Foie de l\u2019Enfant, Unit\u00e9 de Gastroent\u00e9rologie H\u00e9patologie et Nutrition P\u00e9diatriques, D\u00e9partement Femme Enfant Adolescent, Universit\u00e9 de Gen\u00e8ve, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-5738","authenticated-orcid":false,"given":"Simon","family":"Bomken","sequence":"additional","affiliation":[{"name":"23Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Bishop","sequence":"additional","affiliation":[{"name":"24Royal Aberdeen Children\u2019s Hospital Foresterhill, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Penn","sequence":"additional","affiliation":[{"name":"25Manchester University, National Health Service Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Naeije","sequence":"additional","affiliation":[{"name":"9Department of Hemato-Oncology, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Kabbara","sequence":"additional","affiliation":[{"name":"26Division Pediatric Hematology Oncology, Centre Hospitalier du Nord, affiliated with Saint Joseph University, Beirut, Lebanon"},{"name":"27Pediatric Hematology Oncology, Rafic Hariri University Hospital, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-0463","authenticated-orcid":false,"given":"Paul","family":"Milne","sequence":"additional","affiliation":[{"name":"28National Institute for Health and Care Research Newcastle Biomedical Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"H\u00e9lias-Rodzewicz","sequence":"additional","affiliation":[{"name":"29Service de Pathologie, Universit\u00e9 Paris-Saclay, EA4340-BECCOH, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kolenova","sequence":"additional","affiliation":[{"name":"30Hemato Oncology Unit, Brastislava Universty, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Renard","sequence":"additional","affiliation":[{"name":"31Institut d\u2019H\u00e9mato-Oncologie P\u00e9diatrique, Hospice Civil de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perinne Marec","family":"Berard","sequence":"additional","affiliation":[{"name":"31Institut d\u2019H\u00e9mato-Oncologie P\u00e9diatrique, Hospice Civil de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-1955","authenticated-orcid":false,"given":"Julian","family":"Thalhammer","sequence":"additional","affiliation":[{"name":"32Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pagnier","sequence":"additional","affiliation":[{"name":"33Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Salmon","sequence":"additional","affiliation":[{"name":"34Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0231-4460","authenticated-orcid":false,"given":"Nathalie","family":"Aladjidi","sequence":"additional","affiliation":[{"name":"35Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2908-5768","authenticated-orcid":false,"given":"Laura","family":"Olivier","sequence":"additional","affiliation":[{"name":"36Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saultier","sequence":"additional","affiliation":[{"name":"37Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Marseille La Timone, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1644-1473","authenticated-orcid":false,"given":"Laurence","family":"Blanc","sequence":"additional","affiliation":[{"name":"38Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-233X","authenticated-orcid":false,"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[{"name":"39Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Schneider","sequence":"additional","affiliation":[{"name":"40Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Rouen, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Hessissen","sequence":"additional","affiliation":[{"name":"41Centre Hospitalier Universitaire Ibn Sina\u2013Souissi, Rabat, Marocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Golan","sequence":"additional","affiliation":[{"name":"42The Division of Pediatric Hemato-Oncology, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-7578","authenticated-orcid":false,"given":"Sarah","family":"Elitzur","sequence":"additional","affiliation":[{"name":"43Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Ben Arush","sequence":"additional","affiliation":[{"name":"44Pediatric Oncology, Rambam Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Ashkenazi","family":"Lustig","sequence":"additional","affiliation":[{"name":"44Pediatric Oncology, Rambam Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Dvir","sequence":"additional","affiliation":[{"name":"45Pediatric Oncology, Tel Aviv-Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2612-7934","authenticated-orcid":false,"given":"Anna","family":"Raciborska","sequence":"additional","affiliation":[{"name":"46Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Malas","sequence":"additional","affiliation":[{"name":"46Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7154-8814","authenticated-orcid":false,"given":"Safiatou","family":"Diallo","sequence":"additional","affiliation":[{"name":"47H\u00e9mato-Oncologie, Immunologie et Transplantation, H\u00f4pital Universitaire des Enfants Reine Fabiola, Universit\u00e9 libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Levy","sequence":"additional","affiliation":[{"name":"48Service d'h\u00e9mato oncologie p\u00e9diatrique, Clinique St Luc, Louvain, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Efremova","sequence":"additional","affiliation":[{"name":"49Pediatric hemato oncology unit, University Hospital, Minsk, Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Cheng","family":"Munthe-Kaas","sequence":"additional","affiliation":[{"name":"50Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-8035","authenticated-orcid":false,"given":"Tatiana","family":"von Bahr Greenwood","sequence":"additional","affiliation":[{"name":"51Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-4311","authenticated-orcid":false,"given":"Guido","family":"Felizzia","sequence":"additional","affiliation":[{"name":"52Hematology-Oncology Unit, Paediatric Hospital Dr. Juan P. Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Braier","sequence":"additional","affiliation":[{"name":"52Hematology-Oncology Unit, Paediatric Hospital Dr. Juan P. Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-1856","authenticated-orcid":false,"given":"Houda","family":"Boudiaf","sequence":"additional","affiliation":[{"name":"53H\u00e9mato-Oncologie P\u00e9diatrique, Centre Hospitalier Universitaire Mustafa, Alger, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2275-0896","authenticated-orcid":false,"given":"Ilhem","family":"Ben Fraj","sequence":"additional","affiliation":[{"name":"54Department of Pediatrics: Immunology, Hematology and Stem Cell Transplantation, National Bone Marrow Transplant Center, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-4072","authenticated-orcid":false,"given":"Karel","family":"Svojgr","sequence":"additional","affiliation":[{"name":"55Department of Pediatric Hematology and Oncology, University Hospital Motol and 2nd Faculty of Medicine, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Krenova","sequence":"additional","affiliation":[{"name":"56Department of Paediatric Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanette","family":"Bernard","sequence":"additional","affiliation":[{"name":"57Unit\u00e9 d\u2019Onco-H\u00e9matologie P\u00e9diatrique, H\u00f4pitaux Universitaires de Gen\u00e8ve, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-8341","authenticated-orcid":false,"given":"Cecile","family":"Adam","sequence":"additional","affiliation":[{"name":"58Unit\u00e9 d\u2019Onco-H\u00e9matologie P\u00e9diatrique, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Karaoli","sequence":"additional","affiliation":[{"name":"59Pediatric Oncology-Hematology Department, Archbishop Makarios Hospital III, Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8241-4838","authenticated-orcid":false,"given":"Ines Ackerl","family":"Kristensen","sequence":"additional","affiliation":[{"name":"60Department of Clinical Medicine\u2013Department of Oncology Aarhus, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dahl","sequence":"additional","affiliation":[{"name":"61Pediatric Hemato Oncology Unit, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-8098","authenticated-orcid":false,"given":"Irene","family":"Trambusti","sequence":"additional","affiliation":[{"name":"4Department of Hematology and Oncology, Meyer Children\u2019s Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gaspari","sequence":"additional","affiliation":[{"name":"62Pediatric Hematology\/Oncology Department, Cell and Gene Therapy, Scientific Institute for Research, Istituto di Ricovero e Cura a Carattere Scientifico Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"De Fusco","sequence":"additional","affiliation":[{"name":"63Department of Haematology, Azienda Ospedaliera di Rilievo Nazionale \u201cSantobono-Pausilipon,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Chiaravalli","sequence":"additional","affiliation":[{"name":"64Pediatric Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Corti","sequence":"additional","affiliation":[{"name":"65Pediatric Hematology-Oncology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Todesco","sequence":"additional","affiliation":[{"name":"66Pediatric Hemato-Oncology Unit, University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-7799","authenticated-orcid":false,"given":"Vassilios","family":"Papadakis","sequence":"additional","affiliation":[{"name":"67Marianna V Vardinoyanni Oncology Unit\u2013ELPIDA, Department of Pediatric Hematology-Oncology, Agia Sofia Children's Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-5585","authenticated-orcid":false,"given":"Ines","family":"Luz","sequence":"additional","affiliation":[{"name":"68Servi\u00e7o de Oncologia Pedi\u00e1trica, Hospital Pedi\u00e1trico\u2013Unidade Local de Sa\u00fade, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Costa","sequence":"additional","affiliation":[{"name":"69Servi\u00e7o de Oncologia Pedi\u00e1trica, Hospital Pedi\u00e1trico, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-9332","authenticated-orcid":false,"given":"Daria","family":"Osipova","sequence":"additional","affiliation":[{"name":"2Department of Hematopoietic Stem Cell Transplantation, Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-2019","authenticated-orcid":false,"given":"Evelina","family":"Lyudovskikh","sequence":"additional","affiliation":[{"name":"2Department of Hematopoietic Stem Cell Transplantation, Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0093","authenticated-orcid":false,"given":"Michael","family":"Maschan","sequence":"additional","affiliation":[{"name":"2Department of Hematopoietic Stem Cell Transplantation, Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0694-3996","authenticated-orcid":false,"given":"Gleb","family":"Bronin","sequence":"additional","affiliation":[{"name":"70Morozov Children\u2019s Hospital, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgueni","family":"Burcev","sequence":"additional","affiliation":[{"name":"70Morozov Children\u2019s Hospital, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Idbaih","sequence":"additional","affiliation":[{"name":"71Service de Neuro-Oncologie-Institut de Neurologie, H\u00f4pitaux Universitaires La Piti\u00e9\u2013Salp\u00eatri\u00e8re-Charles Foix, Sorbonne Universit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, Institut du Cerveau\u2013Paris Brain Institute, INSERM, Centre National de la Recherche Scientifique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-5342","authenticated-orcid":false,"given":"Islam Amine","family":"Larabi","sequence":"additional","affiliation":[{"name":"72Service de Pharmacologie\u2013Toxicologie, H\u00f4pital Raymond-Poincar\u00e9, Groupe Hospitalier Universitaires Paris-Saclay, Assistance Publique\u2013H\u00f4pitaux de Paris, Garches, France"},{"name":"74Plateforme MONITOR, INSERM U-1018, Centre de Recherche en Epid\u00e9miologie et Sant\u00e9 des Populations, \u00c9quipe MOODS, Paris-Saclay University, Garches, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bellouard","sequence":"additional","affiliation":[{"name":"72Service de Pharmacologie\u2013Toxicologie, H\u00f4pital Raymond-Poincar\u00e9, Groupe Hospitalier Universitaires Paris-Saclay, Assistance Publique\u2013H\u00f4pitaux de Paris, Garches, France"},{"name":"74Plateforme MONITOR, INSERM U-1018, Centre de Recherche en Epid\u00e9miologie et Sant\u00e9 des Populations, \u00c9quipe MOODS, Paris-Saclay University, Garches, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-9475","authenticated-orcid":false,"given":"Jean-Claude","family":"Alvarez","sequence":"additional","affiliation":[{"name":"72Service de Pharmacologie\u2013Toxicologie, H\u00f4pital Raymond-Poincar\u00e9, Groupe Hospitalier Universitaires Paris-Saclay, Assistance Publique\u2013H\u00f4pitaux de Paris, Garches, France"},{"name":"74Plateforme MONITOR, INSERM U-1018, Centre de Recherche en Epid\u00e9miologie et Sant\u00e9 des Populations, \u00c9quipe MOODS, Paris-Saclay University, Garches, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-7712","authenticated-orcid":false,"given":"Olga","family":"Novosad","sequence":"additional","affiliation":[{"name":"73National Cancer Institute, Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-9586","authenticated-orcid":false,"given":"Matthew","family":"Collin","sequence":"additional","affiliation":[{"name":"28National Institute for Health and Care Research Newcastle Biomedical Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-2126","authenticated-orcid":false,"given":"Jan Inge","family":"Henter","sequence":"additional","affiliation":[{"name":"51Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-4466","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[{"name":"29Service de Pathologie, Universit\u00e9 Paris-Saclay, EA4340-BECCOH, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-6370","authenticated-orcid":false,"given":"S\u00e9bastien","family":"H\u00e9ritier","sequence":"additional","affiliation":[{"name":"1French Reference Center for Langerhans Cell Histiocytosis, Assistance Publique des Hopitaux de Paris, Trousseau Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-8423","authenticated-orcid":false,"given":"Milen","family":"Minkov","sequence":"additional","affiliation":[{"name":"6St Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"10295","key":"2026052611213955900_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(21)00311-1","article-title":"Histiocytosis","volume":"398","author":"Emile","year":"2021","journal-title":"Lancet"},{"issue":"31","key":"2026052611213955900_bib2","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: An international observational study","volume":"37","author":"Donadieu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"15","key":"2026052611213955900_bib3","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2018-10-878363","article-title":"Clinical responses and persistent BRAF V600E(+) blood cells in children with LCH treated with MAPK pathway inhibition","volume":"133","author":"Eckstein","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2026052611213955900_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4143\/crt.2020.769","article-title":"Effectiveness and safety of dabrafenib in the treatment of 20 chinese children with BRAFV600E-mutated Langerhans cell histiocytosis","volume":"53","author":"Yang","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"9","key":"2026052611213955900_bib5","doi-asserted-by":"crossref","first-page":"e29140","DOI":"10.1002\/pbc.29140","article-title":"Cutaneous adverse events in children treated with vemurafenib for refractory BRAF(V600E) mutated Langerhans cell histiocytosis","volume":"68","author":"Tardieu","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"2026052611213955900_bib6","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/bloodadvances.2022009067","article-title":"Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH","volume":"7","author":"Evseev","year":"2023","journal-title":"Blood Adv"},{"issue":"15","key":"2026052611213955900_bib7","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/bloodadvances.2022008414","article-title":"Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis","volume":"7","author":"Whitlock","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"2026052611213955900_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/bloodadvances.2021005442","article-title":"Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis","volume":"6","author":"Eder","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"2026052611213955900_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41390-018-0238-y","article-title":"Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis","volume":"85","author":"Schwentner","year":"2018","journal-title":"Pediatr Res"},{"issue":"2","key":"2026052611213955900_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2026052611213955900_bib11","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/bjh.19483","article-title":"Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib","volume":"204","author":"Trambusti","year":"2024","journal-title":"Br J Haematol"},{"issue":"6","key":"2026052611213955900_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12185-021-03205-8","article-title":"Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA","volume":"114","author":"Evseev","year":"2021","journal-title":"Int J Hematol"},{"issue":"1","key":"2026052611213955900_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/bjh.17781","article-title":"Response to mitogen-activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study","volume":"196","author":"Henter","year":"2021","journal-title":"Br J Haematol"},{"issue":"3","key":"2026052611213955900_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/pde.15512","article-title":"Treatment of congenital Langerhans cell histiocytosis with cobimetinib","volume":"41","author":"Benjelloun","year":"2024","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"2026052611213955900_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2016003533","article-title":"Targeted inhibition of the MAPK pathway: emerging salvage option of progressive life-threatening multisystem LCH","volume":"1","author":"Kolenova","year":"2017","journal-title":"Blood Adv"},{"issue":"4","key":"2026052611213955900_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MPH.0000000000003014","article-title":"Sustained clinical remission of BRAF V600E-mutated Langerhans cell histiocytosis with multiorgan involvement in an infant treated with dabrafenib","volume":"47","author":"Cuntz","year":"2025","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2026052611213955900_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mpo.1306","article-title":"Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis","volume":"38","author":"Braier","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"2026052611213955900_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jpeds.2010.03.001","article-title":"Central nervous system disease in Langerhans cell histiocytosis","volume":"156","author":"Grois","year":"2010","journal-title":"J Pediatr"},{"issue":"15","key":"2026052611213955900_bib19","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.ejca.2006.05.031","article-title":"Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis","volume":"42","author":"Nanduri","year":"2006","journal-title":"Eur J Cancer"},{"issue":"6","key":"2026052611213955900_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3174\/ajnr.A0509","article-title":"Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis","volume":"28","author":"Prosch","year":"2007","journal-title":"Am J Neuroradiol"},{"issue":"1","key":"2026052611213955900_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26784","article-title":"Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: current views and new vistas","volume":"65","author":"Yeh","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2026052611213955900_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.14140","article-title":"Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age","volume":"174","author":"Rigaud","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"2026052611213955900_bib23","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2007-08-106211","article-title":"Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification","volume":"111","author":"Gadner","year":"2008","journal-title":"Blood"},{"issue":"25","key":"2026052611213955900_bib24","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2026052611213955900_bib25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/pbc.20160","article-title":"A new clinical score for disease activity in Langerhans cell histiocytosis","volume":"43","author":"Donadieu","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2026052611213955900_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/pharmaceutics16010005","article-title":"Validation of liquid chromatography coupled with tandem mass spectrometry for the determination of 12 tyrosine kinase inhibitors (TKIs) and their application to therapeutic drug monitoring in adult and pediatric populations","volume":"16","author":"Bellouard","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"2026052611213955900_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14695","article-title":"Circulating cell-free BRAF(V600E) as a biomarker in children with Langerhans cell histiocytosis","volume":"178","author":"Heritier","year":"2017","journal-title":"Br J Haematol"},{"issue":"12","key":"2026052611213955900_bib28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1373\/clinchem.2013.206359","article-title":"Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients","volume":"59","author":"Taly","year":"2013","journal-title":"Clin Chem"},{"issue":"10","key":"2026052611213955900_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2024025625","article-title":"Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads","volume":"145","author":"Thalhammer","year":"2025","journal-title":"Blood"},{"issue":"1","key":"2026052611213955900_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ppul.26717","article-title":"Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis","volume":"59","author":"Heritier","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026052611213955900_bib31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamaoncol.2015.0736","article-title":"Vemurafenib use in an infant for high-risk Langerhans cell histiocytosis","volume":"1","author":"Heritier","year":"2015","journal-title":"JAMA Oncol"},{"issue":"6","key":"2026052611213955900_bib32","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdt015","article-title":"Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients","volume":"24","author":"Boussemart","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"2026052611213955900_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09546634.2013.813897","article-title":"Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2","volume":"25","author":"Ma","year":"2014","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"2026052611213955900_bib34","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/bloodadvances.2021006229","article-title":"Development of BRAFV600E-positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH","volume":"6","author":"Salek","year":"2022","journal-title":"Blood Adv"},{"key":"2026052611213955900_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2022.03.036","article-title":"Langerhans cell histiocytosis and associated malignancies: a retrospective analysis of 270 patients","volume":"172","author":"Bagnasco","year":"2022","journal-title":"Eur J Cancer"},{"issue":"4","key":"2026052611213955900_bib36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjh.15577","article-title":"Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study","volume":"183","author":"Heritier","year":"2018","journal-title":"Br J Haematol"},{"issue":"7672","key":"2026052611213955900_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature23672","article-title":"A somatic mutation in rythron-myeloid progenitors causes neurodegenerative disease","volume":"549","author":"Mass","year":"2017","journal-title":"Nature"},{"issue":"7","key":"2026052611213955900_bib38","doi-asserted-by":"crossref","first-page":"1065.e13-1081.e13","DOI":"10.1016\/j.neuron.2025.02.007","article-title":"Role of clonal inflammatory microglia in histiocytosis-associated neurodegeneration","volume":"113","author":"Vicario","year":"2025","journal-title":"Neuron"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2025018651\/2521807\/blooda_adv-2025-018651-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2025018651\/2521807\/blooda_adv-2025-018651-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:21:47Z","timestamp":1779808907000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/10\/3733\/566586\/Long-term-MAPK-inhibition-of-childhood-refractory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018651","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,26]]},"published":{"date-parts":[[2026,5,26]]}}}